Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2020 Sep 18;134(17):2315-2317.
doi: 10.1042/CS-20200904_COR.

Correction: Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission

No authors listed
Published Erratum

Correction: Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission

No authors listed. Clin Sci (Lond). .
No abstract available

Keywords: COVID-19; Coronavirus; SARS-CoV-2; signaling pathway.

PubMed Disclaimer

Figures

Figure 2
Figure 2. Canonical ACE2 pathway links multiple organ damage in COVID-19
SARS-CoV-2 infection down-regulates ACE2 expression and leads to the production of pro-inflammatory mediators, such as IL-6 [1]. Angiotensin-I (Ang-I) is converted into Ang-II by the ACE in the extracellular space. ACE2 is able to further cleave Ang-II to Ang(1-7), which binds MasR receptors on the cell surface and promotes anti-inflammatory, vasodilation and anti-fibrotic effects [1]. Since ACE2 is down-regulated during viral infection, this event will lead to the accumulation of Ang-II and binding to AT1R receptors on cellular membrane. AT1R signals through JAK-STAT and induces fibrosis, pro-inflammatory gene expression and vasoconstriction [2,3]. Multiple organs express ACE2 and are target for SARS-CoV-2. As they lose ACE2-mediated protection, Ang-II signaling contributes to the pathological findings observed in COVID-19 patients, such as disseminated coagulopathy and acute tissue damage [4].
Figure 3
Figure 3. Signaling pathways involved in COVID-19 pathophysiology
Toll-like receptors (TLRs) 3 and TLR 7/8 recognize SARS-CoV-2 RNA and initiate the inflammatory cascade via type I and type II IFN gene expression and NF-κB nuclear translocation [5,6]. Via NF-κB, the expression of multiple pro-inflammatory genes is stimulated, including pro-IL-1β, pro-IL-18, TNF and IL-6 [7–9]. The virus is also recognized by cytoplasmic NLRP3, which forms, together with ASC and caspase-1 (Casp-1), the inflammasome complex that will cleave and release mature forms of IL-1β and IL-18 [10]. The cytokines IL-1β, IL-18 and TNF bind to specific receptors and promote further NF-κB nuclear translocation and phosphorylation of p38 MAPK, which will lead to great expression of pro-inflammatory cytokines and chemokines [11,12]. IL-6, an important player in COVID-19, binds IL-6R and gp130 receptors to activate JAK/STAT-3 pathway and then contribute to the CRS observed in COVID-19 patients [13].
See this image and copyright information in PMC

Erratum for

References

    1. Gheblawi M., Wang K., Viveiros A., Nguyen Q., Zhong J.-C., Turner A.J. et al. . (2020) Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ. Res. 126, 1456–1474 10.1161/CIRCRESAHA.120.317015 - DOI - PMC - PubMed
    1. Perrotta F., Matera M.G., Cazzola M. and Bianco A. (2020) Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter? Respir. Med. 168, 105996 10.1016/j.rmed.2020.105996 - DOI - PMC - PubMed
    1. Groß S., Jahn C., Cushman S., Bär C. and Thum T. (2020) SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications. J. Mol. Cell Cardiol. 144, 47–53 10.1016/j.yjmcc.2020.04.031 - DOI - PMC - PubMed
    1. Tian S., Xiong Y., Liu H., Niu L., Guo J., Liao M. et al. . (2020) Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod. Pathol. 10–12 - PMC - PubMed
    1. Sabroe I., Parker L.C., Dower S.K. and Whyte M.K.B. (2008) The role of TLR activation in inflammation. J. Patho. 214, 126–135 10.1002/path.2264 - DOI - PubMed

Publication types